Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
Faizan Khan(University of Ottawa), Marc Rodger(McGill University), Timothy Brighton(Prince of Wales Hospital), Mary Cushman(University of Vermont), L. Pinède(Infirmerie Protestante), George A. Wells(University of Ottawa), Elham Sabri(Ottawa Hospital), Harry R. Büller(Amsterdam University Medical Centers), Alvi Rahman(University College London), Sabine Eichinger(Medical University of Vienna), Marc Carrier(University of Ottawa), Paul A. Kyrle(Karl Landsteiner Society), Brian Hutton(Ottawa Hospital), Cecilia Becattini(University of Perugia), Françis Couturaud(Centre Hospitalier Régional Universitaire de Brest), Jeffrey I. Weitz(McMaster University Medical Centre), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Giancarlo Agnelli(University of Perugia), Paolo Prandoni(ANT Foundation Italy Onlus), Anthonie W.A. Lensing(Bayer (Germany)), Clive Kearon(McMaster University), Martin H. Prins(Maastricht University), Gualtiero Palareti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 312
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k